1093 Share Price

Open 12.38 Change Price %
High 12.44 1 Day -0.32 -2.58
Low 12.02 1 Week 0.24 2.03
Close 12.08 1 Month 0.12 1.00
Volume 8157041 1 Year 5.13 73.81
52 Week High 12.72
52 Week Low 6.66
1093 Important Levels
Resistance 2 12.47
Resistance 1 12.31
Pivot 12.18
Support 1 11.85
Support 2 11.69
HKG HongKong Most Active Stocks
0566 3.91 0.00%
0061 0.03 0.00%
1880 6.24 0.00%
1918 18.60 -7.46%
0939 6.43 0.31%
1398 5.40 0.19%
3800 0.87 -7.45%
0582 0.09 0.00%
0364 0.02 0.00%
3988 3.76 0.00%
More..
HKG HongKong Top Gainers Stocks
0736 0.05 25.00%
0802 0.16 23.08%
0630 0.12 20.00%
0076 0.06 20.00%
1280 0.80 19.40%
8321 3.73 16.56%
1178 0.08 14.29%
8129 0.08 14.29%
0559 0.17 13.33%
0431 0.17 13.33%
More..
HKG HongKong Top Losers Stocks
1013 0.04 -20.00%
8019 0.04 -20.00%
8331 1.35 -18.18%
0381 0.05 -16.67%
8002 4.00 -15.97%
8266 0.06 -14.29%
1215 0.06 -14.29%
0943 0.06 -14.29%
8165 0.07 -12.50%
0706 0.07 -12.50%
More..

CSPC Pharmaceutical Group Ltd (HKG: 1093)

1093 Technical Analysis 4
As on 25th Jul 2017 1093 Share Price closed @ 12.08 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.38 & Buy for SHORT-TERM with Stoploss of 11.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
1093 Target for July
1st Target up-side 11.97
2nd Target up-side 12.36
3rd Target up-side 12.76
1st Target down-side 10.83
2nd Target down-side 10.44
3rd Target down-side 10.04
1093 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website
1093 Address
1093
1093 Latest News
Interactive Technical Analysis Chart CSPC Pharmaceutical Group Ltd ( 1093 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CSPC Pharmaceutical Group Ltd
1093 Business Profile
CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs. In addition, it researches and develops approximately 170 products for therapeutic areas of anti-infective, cardio-cerebrovascular, diabetes, neurology, and oncology. Further, the company offers pharmaceutical research and development services; and sewage treatment services. It has operations primarily in the People’s Republic of China, other Asian regions, the Americas, and Europe. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. The company is based in Wan Chai, Hong Kong and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange.